{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:58:37Z","timestamp":1790452717948,"version":"4.1.0"},"reference-count":55,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2016,8,29]],"date-time":"2016-08-29T00:00:00Z","timestamp":1472428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81274004"],"award-info":[{"award-number":["No. 81274004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Ruscogenin, an important steroid sapogenin derived from Ophiopogon japonicus, has been shown to inhibit cerebral ischemic injury. However, its potential molecular action on blood-brain barrier (BBB) dysfunction after stroke remains unclear. This study aimed to investigate the effects of ruscogenin on BBB dysfunction and the underlying mechanisms in middle cerebral artery occlusion\/reperfusion (MCAO\/R)-injured mice and oxygen\u2013glucose deprivation\/reoxygenation (OGD\/R)-injured mouse brain microvascular endothelial cells (bEnd.3). The results demonstrated that administration of ruscogenin (10 mg\/kg) decreased the brain infarction and edema, improved neurological deficits, increased cerebral brain flow (CBF), ameliorated histopathological damage, reduced evans blue (EB) leakage and upregulated the expression of tight junctions (TJs) in MCAO\/R-injured mice. Meanwhile, ruscogenin (0.1\u201310 \u00b5M) treatment increased cell viability and trans-endothelial electrical resistance (TEER) value, decreased sodium fluorescein leakage, and modulated the TJs expression in OGD\/R-induced bEnd.3 cells. Moreover, ruscogenin also inhibited the expression of interleukin-1\u03b2 (IL-1\u03b2) and caspase-1, and markedly suppressed the expression of Nucleotide-binding domain (NOD)-like receptor family, pyrin domain containing 3 (NLRP3) and thiredoxin-interactive protein (TXNIP) in vivo and in vitro. Furthermore, ruscogenin decreased reactive oxygen species (ROS) generation and inhibited the mitogen-activated protein kinase (MAPK) pathway in OGD\/R-induced bEnd.3 cells. Our findings provide some new insights into its potential application for the prevention and treatment of ischemic stroke.<\/jats:p>","DOI":"10.3390\/ijms17091418","type":"journal-article","created":{"date-parts":[[2016,8,29]],"date-time":"2016-08-29T10:18:38Z","timestamp":1472465918000},"page":"1418","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":163,"title":["Ruscogenin Attenuates Cerebral Ischemia-Induced Blood-Brain Barrier Dysfunction by Suppressing TXNIP\/NLRP3 Inflammasome Activation and the MAPK Pathway"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5271-7204","authenticated-orcid":false,"given":"Guosheng","family":"Cao","sequence":"first","affiliation":[{"name":"Jiangsu Key Laboratory of Traditional Chinese Medicine Evaluation and Translational Research, Department of Complex Prescription of Traditional Chinese Medicine, China Pharmaceutical University, Nanjing 211198, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Jiangsu Key Laboratory of Traditional Chinese Medicine Evaluation and Translational Research, Department of Complex Prescription of Traditional Chinese Medicine, China Pharmaceutical University, Nanjing 211198, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Hu","sequence":"additional","affiliation":[{"name":"Jiangsu Key Laboratory of Traditional Chinese Medicine Evaluation and Translational Research, Department of Complex Prescription of Traditional Chinese Medicine, China Pharmaceutical University, Nanjing 211198, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Jiangsu Key Laboratory of Traditional Chinese Medicine Evaluation and Translational Research, Department of Complex Prescription of Traditional Chinese Medicine, China Pharmaceutical University, Nanjing 211198, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyun","family":"Wang","sequence":"additional","affiliation":[{"name":"Jiangsu Key Laboratory of Traditional Chinese Medicine Evaluation and Translational Research, Department of Complex Prescription of Traditional Chinese Medicine, China Pharmaceutical University, Nanjing 211198, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"Yin","sequence":"additional","affiliation":[{"name":"Jiangsu Key Laboratory of Traditional Chinese Medicine Evaluation and Translational Research, Department of Complex Prescription of Traditional Chinese Medicine, China Pharmaceutical University, Nanjing 211198, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Ma","sequence":"additional","affiliation":[{"name":"Cellular and Molecular Biology Center, China Pharmaceutical University, Nanjing 211198, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kecheng","family":"Zhou","sequence":"additional","affiliation":[{"name":"Jiangsu Key Laboratory of Traditional Chinese Medicine Evaluation and Translational Research, Department of Complex Prescription of Traditional Chinese Medicine, China Pharmaceutical University, Nanjing 211198, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Qi","sequence":"additional","affiliation":[{"name":"Jiangsu Key Laboratory of Traditional Chinese Medicine Evaluation and Translational Research, Department of Complex Prescription of Traditional Chinese Medicine, China Pharmaceutical University, Nanjing 211198, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1401-9250","authenticated-orcid":false,"given":"Boyang","family":"Yu","sequence":"additional","affiliation":[{"name":"Jiangsu Key Laboratory of Traditional Chinese Medicine Evaluation and Translational Research, Department of Complex Prescription of Traditional Chinese Medicine, China Pharmaceutical University, Nanjing 211198, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8377-915X","authenticated-orcid":false,"given":"Junping","family":"Kou","sequence":"additional","affiliation":[{"name":"Jiangsu Key Laboratory of Traditional Chinese Medicine Evaluation and Translational Research, Department of Complex Prescription of Traditional Chinese Medicine, China Pharmaceutical University, Nanjing 211198, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,8,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1474-4422(15)00054-X","article-title":"Future directions of acute ischaemic stroke therapy","volume":"14","author":"Fisher","year":"2015","journal-title":"Lancet. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Barrett, K.M., Lal, B.K., and Meschia, J.F. (2015). Stroke: Advances in medical therapy and acute stroke intervention. Curr. Cardiol. Rep.","DOI":"10.1007\/s11886-015-0637-1"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fnins.2015.00040","article-title":"Blood-brain barrier dysfunction in disorders of the developing brain","volume":"9","author":"Moretti","year":"2015","journal-title":"Front. Neurosci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/WCO.0000000000000248","article-title":"Blood-brain barrier breakdown and neovascularization processes after stroke and traumatic brain injury","volume":"28","author":"Prakash","year":"2015","journal-title":"Curr. Opin. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/jcbfm.2014.199","article-title":"Blood-brain barrier breakdown involves four distinct stages of vascular damage in various models of experimental focal cerebral ischemia","volume":"35","author":"Krueger","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.2174\/0929867322666150209154036","article-title":"Inflammatory responses in brain ischemia","volume":"22","author":"Kawabori","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.2147\/DDDT.S67655","article-title":"Studies of selective TNF inhibitors in the treatment of braininjury from stroke and trauma: A review of the evidence to date","volume":"8","author":"Tuttolomondo","year":"2014","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1758-5996-6-28","article-title":"Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke with and without metabolic syndrome","volume":"6","author":"Tuttolomondo","year":"2014","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_9","first-page":"362","article-title":"The impact of microglial activation on blood-brain barrier in brain diseases","volume":"8","author":"Matias","year":"2014","journal-title":"Front. Cell Neurosci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/156720208783565645","article-title":"Blood brain barrier in hypoxic-ischemic conditions","volume":"5","author":"Kaur","year":"2008","journal-title":"Curr. Neurovasc. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fnins.2015.00147","article-title":"Rational modulation of the innate immune system for neuroprotection in ischemic stroke","volume":"9","author":"Amantea","year":"2015","journal-title":"Front. Neurosci."},{"key":"ref_12","first-page":"4787","article-title":"The NLRP3 inflammasome and stroke","volume":"8","author":"Tong","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1089\/ars.2014.6126","article-title":"Role of inflammasome activation in the pathophysiology of vascular diseases of the neurovascular unit","volume":"22","author":"Mohamed","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"370530","DOI":"10.1155\/2014\/370530","article-title":"Chrysophanol inhibits NALP3 inflammasome activation and ameliorates cerebral ischemia\/reperfusion in mice","volume":"2014","author":"Zhang","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.trsl.2015.05.003","article-title":"Therapeutics targeting the inflammasome after central nervous system injury","volume":"167","author":"Dietrich","year":"2016","journal-title":"Transl. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s12035-014-8766-x","article-title":"Thioredoxin-interacting protein: A novel target for neuroprotection in experimental thromboembolic stroke in mice","volume":"51","author":"Ishrat","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.taap.2015.03.010","article-title":"Curcumin attenuates glutamate neurotoxicity in the hippocampus by suppression of ER stress-associated TXNIP\/NLRP3 inflammasome activation in a manner dependent on AMPK","volume":"286","author":"Li","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/jcbfm.2008.60","article-title":"Role of the p38 mitogen-activated protein kinase\/cytosolic phospholipase A2 signaling pathway in blood-brain barrier disruption after focal cerebral ischemia and reperfusion","volume":"28","author":"Nito","year":"2008","journal-title":"J. Cereb Blood Flow. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1248\/bpb.28.1234","article-title":"Anti-inflammatory activities of aqueous extract from Radix Ophiopogon japonicus and its two constituents","volume":"28","author":"Kou","year":"2005","journal-title":"Biol. Pharm. Bull."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1254\/jphs.08083FP","article-title":"Possible mechanism of the anti-inflammatory activity of ruscogenin: Role of intercellular adhesion molecule-1 and nuclear factor-\u03baB","volume":"108","author":"Huang","year":"2008","journal-title":"J. Pharmacol. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1472-6882-14-110","article-title":"Ruscogenin ameliorates diabetic nephropathy by its anti-inflammatory and anti-fibrotic effects in streptozotocin-induced diabetic rat","volume":"14","author":"Lu","year":"2014","journal-title":"BMC Complement. Altern. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jsbmb.2015.06.003","article-title":"Ruscogenin suppresses mouse neutrophil activation: Involvement of protein kinase A pathway","volume":"154","author":"Lin","year":"2015","journal-title":"J. Steroid Biochem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ejphar.2013.07.036","article-title":"Ruscogenin reduces cerebral ischemic injury via NF-\u03baB-mediated inflammatory pathway in the mouse model of experimental stroke","volume":"714","author":"Guan","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000441104","article-title":"Stroke prevention worldwide-what could make it work","volume":"45","author":"Norrving","year":"2015","journal-title":"Neuroepidemiology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0140-6736(16)30511-6","article-title":"The benefits of aspirin in early secondary stroke prevention","volume":"388","author":"Hankey","year":"2016","journal-title":"Lancet"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.2174\/1871527313666141023094720","article-title":"Inflammation in ischemic stroke: Mechanisms, consequences and possible drug targets","volume":"13","author":"Ahmad","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.neuint.2012.11.009","article-title":"Neuronal oxidative stress in acute ischemic stroke: Sources and contribution to cell injury","volume":"62","author":"Manzanero","year":"2013","journal-title":"Neurochem. Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00441-014-1811-2","article-title":"Novel insights into the development and maintenance of the blood-brain barrier","volume":"355","author":"Engelhardt","year":"2014","journal-title":"Cell Tissue Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.nbd.2008.08.005","article-title":"Blood-brain barrier tight junction permeability and ischemic stroke","volume":"32","author":"Sandoval","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/WNR.0000000000000464","article-title":"Tight junction disruption of blood-brain barrier in white matter lesions in chronic hypertensive rats","volume":"26","author":"Fan","year":"2015","journal-title":"Neuroreport"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1586\/14737175.2015.1035712","article-title":"Systemic inflammation as a therapeutic target in acute ischemic stroke","volume":"15","author":"Dziedzic","year":"2015","journal-title":"Expert Rev. Neurother."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"772","DOI":"10.2741\/4336","article-title":"Inflammation in the pathogenesis of ischemic stroke","volume":"20","author":"Pei","year":"2015","journal-title":"Front. Biosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pneurobio.2007.07.008","article-title":"Tumor necrosis factor and stroke: Role of the blood-brain barrier","volume":"83","author":"Pan","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1038\/jcbfm.2014.159","article-title":"Molecular regulation of cell fate in cerebral ischemia: Role of the inflammasome and connected pathways","volume":"34","author":"Trendelenburg","year":"2014","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.arr.2013.09.004","article-title":"Pathogenesis of acute stroke and the role of inflammasomes","volume":"12","author":"Fann","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1073\/pnas.1419090112","article-title":"AIM2 and NLRC4 inflammasomes contribute with ASC to acute brain injury independently of NLRP3","volume":"112","author":"Denes","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.expneurol.2014.04.017","article-title":"Intermittent fasting attenuates inflammasome activity in ischemic stroke","volume":"257","author":"Fann","year":"2014","journal-title":"Exp. Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/jcbfm.2013.242","article-title":"NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke","volume":"34","author":"Yang","year":"2014","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e790","DOI":"10.1038\/cddis.2013.326","article-title":"Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke","volume":"4","author":"Fann","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"28734","DOI":"10.1038\/srep28734","article-title":"New insights into salvianolic acid A action: Regulation of the TXNIP\/NLRP3 and TXNIP\/ChREBP pathways ameliorates HFD-induced NAFLD in rats","volume":"6","author":"Ding","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neulet.2015.06.016","article-title":"Umbelliferone ameliorates cerebral ischemia-reperfusion injury via upregulating the PPAR gamma expression and suppressing TXNIP\/NLRP3 inflammasome","volume":"600","author":"Wang","year":"2015","journal-title":"Neurosci. Lett."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1089\/ars.2012.4757","article-title":"The thioredoxin system as a therapeutic target in human health and disease","volume":"19","author":"Mahmood","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbadis.2012.10.003","article-title":"Overexpression of HSPA12B protects against cerebral ischemia\/reperfusion injury via a PI3K\/Akt-dependent mechanism","volume":"1832","author":"Ma","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1463-1326.2008.00987.x","article-title":"Antioxidants attenuate hyperglycaemia-mediated brain endothelial cell dysfunction and blood-brain barrier hyperpermeability","volume":"11","author":"Allen","year":"2009","journal-title":"Diabetes. Obes. Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jep.2016.02.028","article-title":"YiQiFuMai Powder Injection ameliorates the oxygen-glucose deprivation-induced brain microvascular endothelial barrier dysfunction associated with the NF-\u03baB and ROCK1\/MLC signaling pathways","volume":"183","author":"Cao","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","article-title":"Reversible middle cerebral artery occlusion without craniectomy in rats","volume":"20","author":"Longa","year":"1989","journal-title":"Stroke"},{"key":"ref_47","first-page":"315","article-title":"YiQiFuMai powder injection ameliorates blood-brain barrier dysfunction and brain edema after focal cerebral ischemia-reperfusion injury in mice","volume":"10","author":"Cao","year":"2016","journal-title":"Drug. Des. Dev. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/STROKEAHA.113.003033","article-title":"Deferoxamine attenuates white matter injury in a piglet intracerebral hemorrhage model","volume":"45","author":"Xie","year":"2014","journal-title":"Stroke"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1212\/WNL.59.4.514","article-title":"Human marrow stromal cell therapy for stroke in rat: Neurotrophins and functional recovery","volume":"59","author":"Li","year":"2002","journal-title":"Neurology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/jnr.23400","article-title":"A combination of four active compounds alleviates cerebral ischemia-reperfusion injury in correlation with inhibition of autophagy and modulation of AMPK\/mTOR and JNK pathways","volume":"92","author":"Guo","year":"2014","journal-title":"J. Neurosci. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1161\/STROKEAHA.112.670299","article-title":"CXCR4 antagonist AMD3100 protects blood-brain barrier integrity and reduces inflammatory response after focal ischemia in mice","volume":"44","author":"Huang","year":"2013","journal-title":"Stroke"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/978-1-61779-191-8_25","article-title":"Assessment of permeability in barrier type of endothelium in brain using tracers: Evans blue, sodium fluorescein, and horseradish peroxidase","volume":"763","author":"Kaya","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.phrs.2015.05.012","article-title":"Ilexgenin A inhibits endoplasmic reticulum stress and ameliorates endothelial dysfunction via suppression of TXNIP\/NLRP3 inflammasome activation in an AMPK dependent manner","volume":"99","author":"Li","year":"2015","journal-title":"Pharmacol. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5493279","DOI":"10.1155\/2016\/5493279","article-title":"YiQiFuMai powder injection ameliorates cerebral ischemia by inhibiting endoplasmic reticulum stress-mediated neuronal apoptosis","volume":"2016","author":"Cao","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neuropharm.2016.02.002","article-title":"Nafamostat mesilate protects against acute cerebral ischemia via blood-brain barrier protection","volume":"105","author":"Wang","year":"2016","journal-title":"Neuropharmacology"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/9\/1418\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:29:30Z","timestamp":1760210970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/9\/1418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,29]]},"references-count":55,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9]]}},"alternative-id":["ijms17091418"],"URL":"https:\/\/doi.org\/10.3390\/ijms17091418","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,29]]}}}